Covid-19 vac­cine halt drags on, an FDA ap­point­ment at long last, the great CRO con­sol­i­da­tion, and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

Con­fer­ence sea­son is up­on us, and while we’d much pre­fer to be wan­der­ing down the hall­ways and pre­sen­ta­tion rooms in per­son, the team is ready to cov­er the most con­se­quen­tial da­ta com­ing out of these sci­en­tif­ic meet­ings. Get in touch ear­ly if you have news to share.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.